Potential impact of single-risk-factor versus total risk management for the prevention of cardiovascular events in Seychelles
Roger Ndindjock, Jude Gedeon, Shanthi Mendis, Fred Paccaud & Pascal Bovet
Volume 89, Number 4, April 2011, 286-295
Table 1. Relative risk of fatal and non-fatal cardiovascular (CV) events associated with the use of selected CV risk management strategies, Seychelles
|Management strategy and medication||RRa
|Serum cholesterol ≥ 6.2 mmol/l|
|Blood pressure ≥ 140/90 mmHg|
|Three classes of drugs||0.67||0.76||0.70|
|Total CV risk||0.84||0.68||0.79|
CE, coronary event; RR, relative risk.
a See text for explanations and references underlying the RR estimates provided in this table. The RR of experiencing a CV event was calculated from the risk factor reductions obtained with the low-dose polycap. An incidence ratio of stroke to coronary events of 2:1 was assumed.18
b Includes unstable angina and myocardial infarction.
c Includes both stroke and coronary events.
d Composed of aspirin, a statin, a diuretic and an angiotensin-converting enzyme inhibitor.